Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 3
1952 2
1953 5
1954 5
1955 4
1956 4
1957 4
1958 6
1959 5
1961 1
1963 99
1964 174
1965 69
1966 1
1967 3
1968 7
1969 10
1970 5
1971 2
1972 7
1973 4
1974 7
1975 4
1976 10
1977 9
1978 8
1979 3
1980 2
1981 7
1982 1
1983 1
1984 8
1985 4
1986 3
1987 7
1988 7
1989 8
1990 7
1991 5
1992 13
1993 13
1994 18
1995 10
1996 19
1997 22
1998 28
1999 46
2000 43
2001 41
2002 70
2003 51
2004 63
2005 84
2006 68
2007 116
2008 122
2009 102
2010 123
2011 159
2012 149
2013 148
2014 226
2015 260
2016 241
2017 260
2018 273
2019 270
2020 291
2021 323
2022 325
2023 351
2024 175

Text availability

Article attribute

Article type

Publication date

Search Results

4,545 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Risbol
Page 1
Did you mean sole ristol (1 results)?
Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study.
McDade E, Cummings JL, Dhadda S, Swanson CJ, Reyderman L, Kanekiyo M, Koyama A, Irizarry M, Kramer LD, Bateman RJ. McDade E, et al. Alzheimers Res Ther. 2022 Dec 21;14(1):191. doi: 10.1186/s13195-022-01124-2. Alzheimers Res Ther. 2022. PMID: 36544184 Free PMC article. Clinical Trial.
The objective of this analysis is to report results from study 201 blinded period (core), the open-label extension (OLE), and gap period (between core and OLE) supporting the effectiveness of lecanemab. ...In the OLE, lecanemab 10 mg/kg biweekly treatment pro …
The objective of this analysis is to report results from study 201 blinded period (core), the open-label extension (OLE), and gap per …
Survival analyses from the CENTAUR trial in amyotrophic lateral sclerosis: Evaluating the impact of treatment crossover on outcomes.
Paganoni S, Watkins C, Cawson M, Hendrix S, Dickson SP, Knowlton N, Timmons J, Manuel M, Cudkowicz M. Paganoni S, et al. Muscle Nerve. 2022 Aug;66(2):136-141. doi: 10.1002/mus.27569. Epub 2022 May 31. Muscle Nerve. 2022. PMID: 35508892 Free PMC article. Clinical Trial.
Analyses of subgroups based on randomized treatment and OLE phase participation were also performed. RESULTS: Hazard ratios (95% confidence intervals) of death for PB and TURSO versus participants initially on placebo were 0.57 (0.35-0.92) on ITT analysis and 0.39 (0.17-0. …
Analyses of subgroups based on randomized treatment and OLE phase participation were also performed. RESULTS: Hazard ratios (95% conf …
Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study.
Zouboulis CC, Okun MM, Prens EP, Gniadecki R, Foley PA, Lynde C, Weisman J, Gu Y, Williams DA, Jemec GBE. Zouboulis CC, et al. J Am Acad Dermatol. 2019 Jan;80(1):60-69.e2. doi: 10.1016/j.jaad.2018.05.040. Epub 2018 Jun 1. J Am Acad Dermatol. 2019. PMID: 29860040 Clinical Trial.
METHODS: The durations of the PIONEER I/II periods A, B, and OLE were 12, 24, and 52 or more weeks, respectively. Patients who entered the OLE and received ADA (40 mg every week continuously) and responders plus partial responders (PRRs) were evaluated. ...LIMITATIO …
METHODS: The durations of the PIONEER I/II periods A, B, and OLE were 12, 24, and 52 or more weeks, respectively. Patients who entere …
Control of membrane fluidity: the OLE pathway in focus.
Ballweg S, Ernst R. Ballweg S, et al. Biol Chem. 2017 Feb 1;398(2):215-228. doi: 10.1515/hsz-2016-0277. Biol Chem. 2017. PMID: 27787227 Free article. Review.
Saccharomyces cerevisiae is an ideal model organism to study the regulation of the lipid acyl chain composition via the OLE pathway. The OLE pathway comprises all steps involved in the regulated mobilization of the transcription factors Mga2 and Spt23 from the endop …
Saccharomyces cerevisiae is an ideal model organism to study the regulation of the lipid acyl chain composition via the OLE pathway. …
Ole e 3, a Candidate for in vivo Diagnosis of Polcalcin Sensitization.
Moya R, González-Ruiz A, Beitia JM, Carnés J, López-Matas MÁ. Moya R, et al. Int Arch Allergy Immunol. 2021;182(6):465-473. doi: 10.1159/000512303. Epub 2021 Jan 18. Int Arch Allergy Immunol. 2021. PMID: 33461195
Ole e 3 enabled diagnosis of polcalcin-sensitized patients, and a good correlation was revealed with ImmunoCAP. A 50% inhibition in IgE binding was obtained with 2.8 ng of Ole e 3 for rBet v 4 and 3.9 ng for rPhl p 7. DISCUSSION/CONCLUSION: Native Ole e 3 was …
Ole e 3 enabled diagnosis of polcalcin-sensitized patients, and a good correlation was revealed with ImmunoCAP. A 50% inhibition in I …
Durable biochemical response and safety with oral octreotide capsules in acromegaly.
Samson SL, Nachtigall LB, Fleseriu M, Jensterle M, Manning PJ, Elenkova A, Molitch ME, Ludlam WH, Patou G, Haviv A, Biermasz NR, Giustina A, Strasburger CJ, Kennedy L, Melmed S. Samson SL, et al. Eur J Endocrinol. 2022 Oct 26;187(6):733-741. doi: 10.1530/EJE-22-0220. Print 2022 Dec 1. Eur J Endocrinol. 2022. PMID: 36173649 Free PMC article. Clinical Trial.
DESIGN: The study design is an OLE of a double-blind placebo-controlled (DPC) trial. METHODS: Patients completing the 36-week DPC period on the study drug (OOC or placebo) or meeting predefined withdrawal criteria were eligible for OLE enrollment at 60 mg/day OOC do …
DESIGN: The study design is an OLE of a double-blind placebo-controlled (DPC) trial. METHODS: Patients completing the 36-week DPC per …
Ornate, large, extremophilic (OLE) RNA forms a kink turn necessary for OapC protein recognition and RNA function.
Lyon SE, Harris KA, Odzer NB, Wilkins SG, Breaker RR. Lyon SE, et al. J Biol Chem. 2022 Dec;298(12):102674. doi: 10.1016/j.jbc.2022.102674. Epub 2022 Nov 3. J Biol Chem. 2022. PMID: 36336078 Free PMC article.
In the current study, we used in vivo crosslinking followed by OLE RNA isolation to identify the protein YbxF as a potential additional partner in the OLE RNP complex. ...Moreover, B. halodurans cells carrying OLE RNAs with disruptive mutations in the k-turn …
In the current study, we used in vivo crosslinking followed by OLE RNA isolation to identify the protein YbxF as a potential addition …
Adult occipital lobe epilepsy: 12-years on.
Angus-Leppan H, Clay TA. Angus-Leppan H, et al. J Neurol. 2021 Oct;268(10):3926-3934. doi: 10.1007/s00415-021-10557-y. Epub 2021 Apr 26. J Neurol. 2021. PMID: 33900448
METHODS: 24 adult OLE patients identified over 12 months from 1548 patients in a neurologist's service were followed over 12 years. ...CONCLUSION: Adult OLE accounted for 7.7% of focal epilepsies in this cohort, misdiagnosed or misclassified in 40%. ...
METHODS: 24 adult OLE patients identified over 12 months from 1548 patients in a neurologist's service were followed over 12 years. . …
Olive Leaf Extract (OLE) Addition as Tool to Reduce Nitrate and Nitrite in Ripened Sausages.
Difonzo G, Totaro MP, Caponio F, Pasqualone A, Summo C. Difonzo G, et al. Foods. 2022 Feb 3;11(3):451. doi: 10.3390/foods11030451. Foods. 2022. PMID: 35159601 Free PMC article.
Seven formulations of pork sausages were set up: CTRL (0 mg/kg OLE; 300 mg/kg NO), Tr1 (200 mg/kg OLE; 150 mg/kg NO), Tr2 (400 mg/kg OLE; 150 mg/kg NO), Tr3 (800 mg/kg OLE; 150 mg/kg NO), Tr4 (200 mg/kg OLE; 0 mg/kg NO), Tr5 (400 mg/kg OLE …
Seven formulations of pork sausages were set up: CTRL (0 mg/kg OLE; 300 mg/kg NO), Tr1 (200 mg/kg OLE; 150 mg/kg NO), Tr2 (400 …
4,545 results